Nonsynonimous mutation of catechol-O-methyl-transferase (COMT) gene in a patient with temporomandibular disorder(157 visite) D'Antò V, Michelotti A, Esposito L, Zagari A, Liguori R, Sacchetti L
J Sci Med Sport (ISSN: 1440-2440), 2010; 13(6): 174-179.
Tipo di articolo: Journal Article,
Impact factor: 3.194, Impact factor a 5 anni: 3.834
Parole chiave: Comt Gene, Disc Displacement Without Reduction, Mutation, Pain Sensitivity, Temporomandibular Joint Disorders, Catechol Methyltransferase, Genomic Dna, Adult, Article, Case Report, Clinical Assessment, Crystallography, Dna Sequence, Female, Gene Expression, Gene Mutation, Human, Jaw Disease, Masticatory Muscle, Myofascial Pain, Nociception, Nuclear Magnetic Resonance Imaging, Pain Assessment, Visual Analog Scale, Adenine, Agents Interacting With Transmitter, Hormone Or Drug Receptors, Arginine, Cytosine, Serine, Codon, Dislocation, Genetics, Joint Characteristics And Functions, Pathology, Physiology, Catechol O-Methyltransferase, Neurotransmitter Agents, Pain Measurement, Range Of Motion, Articular, Temporomandibular Joint Dysfunction Syndrome,
Affiliazioni:
*** IBB - CNR *** Department of Oral and Maxillofacial Surgery, University of Naples Federico II, Italy Institute of biostructure and bioimaging, CNR, Naples, Italy CEINGE Biotecnologie Avanzate S.C.a R.L, Naples, Italy Department of Biochemistry and Medical Biotechnology, University of Naples Federico II, Italy
Riferimenti:
Cairns, B.E., Pathophysiology of TMD pain - basic mechanisms and their implications for pharmacotherapy (2010) J Oral Rehabil, 37, pp. 391-41
Scrivani, S.J., Keith, D.A., Kaban, L.B., Temporomandibular disorders (2008) N Engl J Med, 359, pp. 2693-2705
Von Korff, M., Le Resche, L., Dworkin, S.F., First onset of common pain symptoms: a prospective study of depression as a risk factor (1993) Pain, 55, pp. 251-258
John, M.T., Miglioretti, D.L., LeResche, L., Von Korff, M., Critchlow, C.W., Widespread pain as a risk factor for dysfunctional temporomandibular disorder pain (2003) Pain, 102, pp. 257-263
Maixner, W., Fillingim, R., Booker, D., Sigurdsson, A., Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain (1995) Pain, 63, pp. 341-351
Von Korff, M.R., Dworkin, S.F., Le Resche, L., Kriger, A., An epidemiologic comparison of pain complaints (1988) Pain, 32, pp. 173-183
Dworkin, S.F., LeResche, L., Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique (1992) J Craniomandib Disord, 6, pp. 301-355
Marbach, J.J., Lipton, J.A., Treatment of patients with temporomandibular joint and other facial pain by otolaryngologist (1982) Arch Otolaryngol, 108, pp. 102-107
Svensson, P., Craniofacial muscle pain: review of mechanisms and clinical manifestations (2001) J Orofacial Pain, 15, pp. 117-145
DeBoever, J.A., Carlsson, G.E., Etiology and differential diagnosis (1994) Temporomandibular joint and masticatory muscle disorders, , Munksgaard, Copenhagen, G.A. Zarb, G.E. Carlsson, B.J. Sessle, N.D. Mohl (Eds.)
Diatchenko, L., Nackley, A.G., Slade, G.D., Fillingim, R.B., Maixner, W., Idiopathic pain disorders-pathways of vulnerability (2006) Pain, 123, pp. 226-230
Nagasako, E.M., Oaklander, A.L., Dworkin, R.H., Congenital insensitivity to pain: an update (2003) Pain, 101, pp. 213-219
Slade, G.D., Diatchenko, L., Ohrbach, R., Maixner, W., Orthodontic Treatment, Genetic Factors and Risk of Temporomandibular Disorder (2008) Semin Orthod, 14, pp. 146-156
Zubieta, J.K., Heitzeg, M.M., Smith, Y.R., Bueller, J.A., Xu, K., Xu, Y., Koeppe, R.A., Goldman, D., COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor (2003) Science, 299, pp. 1240-1243
Diatchenko, L., Slade, G.D., Nackley, A.G., Bhalang, K., Sigurdsson, A., Belfer, I., Goldman, D., Maixner, W., Genetic basis for individual variations in pain perception and the development of a chronic pain condition (2005) Hum Mol Genet, 14, pp. 135-143
Melzack, R., The McGill Pain Questionnaire: Major properties and scoring methods (1975) Pain, 1, pp. 277-299
Rutherford, K., Le Trong, I., Stenkamp, R.E., Parson, W.W., Crystal structures of human 108V and 108M catechol O-methyltransferase (2008) J Mol Biol., 380, pp. 120-130
Raphael, K.G., Marbach, J.J., Widespread pain and the effectiveness of oral splints in myofascial face pain (2001) J Am Dent Assoc, 132, pp. 305-316
Vassend, O., Krogstad, B.S., Dahl, B.L., Negative affectivity, somatic complaints, and symptoms of temporomandibular disorders (1995) J Psychosom Res, 39, pp. 889-899
Beaton, R.D., Egan, K.J., Nakagawa-Kogan, H., Morrison, K.N., Selfreported symptoms of stress with temporomandibular disorders: comparisons to healthy men and women (1991) J Prosthet Dent, 65, pp. 289-293
Piedrafita, F.J., Elorriaga, C., Fernández-Alvarez, E., Nieto, O., Inhibition of catechol-O-methyltransferase by N-(3,4-dihydroxyphenyl) maleimide (1990) J Enzyme Inhib, 4, pp. 43-50
Pérez, R.A., Fernández-Alvarez, E., Nieto, O., Piedrafita, F.J., Kinetics of the reversible tight-binding inhibition of pig liver catechol-O-methyltransferase by [2-(3,4-dihydroxy-2- nitrophenyl)vinyl]phenyl ketone (1994) J Enzyme Inhib, 8, pp. 123-131
Bai, H.W., Shim, J.Y., Yu, J., Zhu, B.T., Biochemical and molecular modeling studies of the O-methylation of various endogenous and exogenous catechol substrates catalyzed by recombinant human soluble and membrane-bound catechol-O-methyltransferases (2007) Chem Res Toxicol., 20, pp. 1409-1425
Li, P.P., Warsh, J.J., Godse, D.D., Formation and clearance of norepinephrine glycol metabolites in mouse brain (1984) J Neurochem., 43, pp. 1425-1433
Pertovaara, A., Noradrenergic pain modulation (2006) Prog Neurobiol, 80, pp. 53-83
Wood, P.B., Role of central dopamine in pain and analgesia (2008) Expert Rev Neurother, 8, pp. 781-797
George, S.R., Kertesz, M., Met-enkephalin concentrations in striatum respond reciprocally to alterations in dopamine neurotransmission (1987) Peptides., 8, pp. 487-492
Chen, J.F., Aloyo, V.J., Weiss, B., Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum (1993) Neuroscience., 54, pp. 669-680
Tchivileva, I.E., Lim, P.F., Smith, S.B., Slade, G.D., Diatchenko, L., McLean, S.A., Maixner, W., Effect of catechol-O-methyltransferase polymorphism on response to propranolol therapy in chronic musculoskeletal pain: a randomized, double-blind, placebo-controlled, crossover pilot study (2010) Pharmacogenet Genomics, 20, pp. 239-248
Cairns, B. E., Pathophysiology of TMD pain - basic mechanisms and their implications for pharmacotherapy (2010) J Oral Rehabil, 37, pp. 391-41
Scrivani, S. J., Keith, D. A., Kaban, L. B., Temporomandibular disorders (2008) N Engl J Med, 359, pp. 2693-2705
John, M. T., Miglioretti, D. L., LeResche, L., Von Korff, M., Critchlow, C. W., Widespread pain as a risk factor for dysfunctional temporomandibular disorder pain (2003) Pain, 102, pp. 257-263
Von Korff, M. R., Dworkin, S. F., Le Resche, L., Kriger, A., An epidemiologic comparison of pain complaints (1988) Pain, 32, pp. 173-183
Dworkin, S. F., LeResche, L., Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique (1992) J Craniomandib Disord, 6, pp. 301-355
Marbach, J. J., Lipton, J. A., Treatment of patients with temporomandibular joint and other facial pain by otolaryngologist (1982) Arch Otolaryngol, 108, pp. 102-107
DeBoever, J. A., Carlsson, G. E., Etiology and differential diagnosis (1994) Temporomandibular joint and masticatory muscle disorders, , Munksgaard, Copenhagen, G. A. Zarb, G. E. Carlsson, B. J. Sessle, N. D. Mohl (Eds.)
Nagasako, E. M., Oaklander, A. L., Dworkin, R. H., Congenital insensitivity to pain: an update (2003) Pain, 101, pp. 213-219
Slade, G. D., Diatchenko, L., Ohrbach, R., Maixner, W., Orthodontic Treatment, Genetic Factors and Risk of Temporomandibular Disorder (2008) Semin Orthod, 14, pp. 146-156
Zubieta, J. K., Heitzeg, M. M., Smith, Y. R., Bueller, J. A., Xu, K., Xu, Y., Koeppe, R. A., Goldman, D., COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor (2003) Science, 299, pp. 1240-1243
Raphael, K. G., Marbach, J. J., Widespread pain and the effectiveness of oral splints in myofascial face pain (2001) J Am Dent Assoc, 132, pp. 305-316
Beaton, R. D., Egan, K. J., Nakagawa-Kogan, H., Morrison, K. N., Selfreported symptoms of stress with temporomandibular disorders: comparisons to healthy men and women (1991) J Prosthet Dent, 65, pp. 289-293
Piedrafita, F. J., Elorriaga, C., Fern ndez-Alvarez, E., Nieto, O., Inhibition of catechol-O-methyltransferase by N- (3, 4-dihydroxyphenyl) maleimide (1990) J Enzyme Inhib, 4, pp. 43-50
P rez, R. A., Fern ndez-Alvarez, E., Nieto, O., Piedrafita, F. J., Kinetics of the reversible tight-binding inhibition of pig liver catechol-O-methyltransferase by [2- (3, 4-dihydroxy-2- nitrophenyl) vinyl] phenyl ketone (1994) J Enzyme Inhib, 8, pp. 123-131
Bai, H. W., Shim, J. Y., Yu, J., Zhu, B. T., Biochemical and molecular modeling studies of the O-methylation of various endogenous and exogenous catechol substrates catalyzed by recombinant human soluble and membrane-bound catechol-O-methyltransferases (2007) Chem Res Toxicol., 20, pp. 1409-1425
Li, P. P., Warsh, J. J., Godse, D. D., Formation and clearance of norepinephrine glycol metabolites in mouse brain (1984) J Neurochem., 43, pp. 1425-1433
Wood, P. B., Role of central dopamine in pain and analgesia (2008) Expert Rev Neurother, 8, pp. 781-797
George, S. R., Kertesz, M., Met-enkephalin concentrations in striatum respond reciprocally to alterations in dopamine neurotransmission (1987) Peptides., 8, pp. 487-492
Chen, J. F., Aloyo, V. J., Weiss, B., Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum (1993) Neuroscience., 54, pp. 669-680
Tchivileva, I. E., Lim, P. F., Smith, S. B., Slade, G. D., Diatchenko, L., McLean, S. A., Maixner, W., Effect of catechol-O-methyltransferase polymorphism on response to propranolol therapy in chronic musculoskeletal pain: a randomized, double-blind, placebo-controlled, crossover pilot study (2010) Pharmacogenet Genomics, 20, pp. 239-248
Bruni AC, Bernardi L, Colao R, Rubino E, Smirne N, Frangipane F, Terni B, Curcio SA, Mirabelli M, Clodomiro A, Di Lorenzo R, Maletta R, Anfossi M, Gallo M, Geracitano S, Tomaino C, Muraca MG, Leotta A, Lio SG, Pinessi L, Rainero I, Sorbi S, Nee L, Milan G, Pappata S, Postiglione A, Abbamondi N, Forloni G, St George Hyslop P, Rogaeva E, Bugiani O, Giaccone G, Foncin JF, Spillantini MG, Puccio G * Worldwide distribution of PSEN1 Met146Leu mutation: A large variability for a founder mutation(136 visite) Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2010 Mar 9; 74(10): 798-806. Impact Factor:8.017 DettagliEsporta in BibTeXEsporta in EndNote
130 Records (118 escludendo Abstract e Conferenze). Impact factor totale: 580.549 (535.161 escludendo Abstract e Conferenze). Impact factor a 5 anni totale: 582.943 (533.364 escludendo Abstract e Conferenze).
ibb.cnr.it